Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -2.06M | -2.18M | -2.29M | -2.28M | -2.29M |
Total Depreciation and Amortization | 95.60K | 96.90K | 97.70K | 107.90K | 119.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 36.60K | 120.10K | 214.80K | 271.70K | 342.20K |
Change in Net Operating Assets | -695.50K | -479.70K | -254.80K | -254.80K | -254.80K |
Cash from Operations | -2.62M | -2.44M | -2.23M | -2.16M | -2.09M |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -10.40K | -5.30K | -- | -- | -- |
Cash from Investing | -10.40K | -5.30K | -- | -- | -- |
Total Debt Issued | 931.60K | 465.80K | -- | -- | -- |
Total Debt Repaid | -77.00K | -75.40K | -73.80K | -72.40K | -71.00K |
Issuance of Common Stock | -- | 3.03M | 6.06M | 7.03M | 8.00M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -303.10K | -606.20K | -661.30K | -716.40K |
Cash from Financing | 564.80K | 2.04M | 3.51M | 4.13M | 4.75M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -2.07M | -404.90K | 1.28M | 1.97M | 2.67M |